These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 30899371)
1. STOML2 as a novel prognostic biomarker modulates cell proliferation, motility and chemo-sensitivity via IL6-Stat3 pathway in head and neck squamous cell carcinoma. Qu H; Jiang W; Wang Y; Chen P Am J Transl Res; 2019; 11(2):683-695. PubMed ID: 30899371 [TBL] [Abstract][Full Text] [Related]
2. Silence of Stomatin-Like Protein 2 Represses Migration and Invasion Ability of Human Liver Cancer Cells via Inhibiting the Nuclear Factor Kappa B (NF-κB) Pathway. Zhu W; Li W; Geng Q; Wang X; Sun W; Jiang H; Pu X Med Sci Monit; 2018 Oct; 24():7625-7632. PubMed ID: 30359340 [TBL] [Abstract][Full Text] [Related]
3. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma. Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371 [TBL] [Abstract][Full Text] [Related]
4. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis. Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of stomatin-like protein 2 (STOML2) reduces the invasive ability of glioma cells through inhibition of the NF-κB/MMP-9 pathway. Song L; Liu L; Wu Z; Lin C; Dai T; Yu C; Wang X; Wu J; Li M; Li J J Pathol; 2012 Feb; 226(3):534-43. PubMed ID: 21960069 [TBL] [Abstract][Full Text] [Related]
6. Rab18 Regulates Proliferation, Invasion and Cisplatin Sensitivity Through STAT3 Signaling in Head and Neck Squamous Cell Carcinoma. Ji X; Guo X; Wang Y; Li X; Li H Onco Targets Ther; 2020; 13():4123-4134. PubMed ID: 32494165 [TBL] [Abstract][Full Text] [Related]
7. EGFRwt/vIII-PKM2-β-catenin cascade affects proliferation and chemo-sensitivity in head and neck squamous cell carcinoma. Jing C; Qu X; Li Z; Wu C; Zhao M; Wang Y; Sun S; Zhang S; Chen J; Qiao Y; Hu X; Yao X; Jin R; Wang X; Zhang L; Zhou X Am J Cancer Res; 2017; 7(12):2491-2502. PubMed ID: 29312802 [TBL] [Abstract][Full Text] [Related]
8. STOML2 interacts with PHB through activating MAPK signaling pathway to promote colorectal Cancer proliferation. Ma W; Chen Y; Xiong W; Li W; Xu Z; Wang Y; Wei Z; Mou T; Wu Z; Cheng M; Zou Y; Zhu Y; Zhou W; Liu F; Geng Y J Exp Clin Cancer Res; 2021 Nov; 40(1):359. PubMed ID: 34781982 [TBL] [Abstract][Full Text] [Related]
9. Coexisting overexpression of STOML1 and STOML2 proteins may be associated with pathology of oral squamous cell carcinoma. Wang D; Qi H; Li A; Deng F; Xu Y; Hu Z; Liu Q; Wang Y Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Jun; 129(6):591-599.e3. PubMed ID: 32402568 [TBL] [Abstract][Full Text] [Related]
10. SOX2-OT Binds with ILF3 to Promote Head and Neck Cancer Progression by Modulating Crosstalk between STAT3 and TGF-β Signaling. Wang R; Yang Y; Wang L; Shi Q; Ma H; He S; Feng L; Fang J Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136312 [TBL] [Abstract][Full Text] [Related]
11. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma. Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539 [TBL] [Abstract][Full Text] [Related]
12. Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation. Chang JW; Jung SN; Kim JH; Shim GA; Park HS; Liu L; Kim JM; Park J; Koo BS Sci Rep; 2016 Jun; 6():28503. PubMed ID: 27328758 [TBL] [Abstract][Full Text] [Related]
13. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma. Kaliyaperumal K; Sharma AK; McDonald DG; Dhindsa JS; Yount C; Singh AK; Won JS; Singh I Redox Biol; 2015 Dec; 6():41-50. PubMed ID: 26177470 [TBL] [Abstract][Full Text] [Related]
14. LAMB3 is associated with disease progression and cisplatin cytotoxic sensitivity in head and neck squamous cell carcinoma. Liu L; Jung SN; Oh C; Lee K; Won HR; Chang JW; Kim JM; Koo BS Eur J Surg Oncol; 2019 Mar; 45(3):359-365. PubMed ID: 30414703 [TBL] [Abstract][Full Text] [Related]
15. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells. Lin HY; Hou SC; Chen SC; Kao MC; Yu CC; Funayama S; Ho CT; Way TD J Agric Food Chem; 2012 Mar; 60(10):2480-9. PubMed ID: 22313388 [TBL] [Abstract][Full Text] [Related]
17. Expression of STOML2 promotes proliferation and glycolysis of multiple myeloma cells via upregulating PAI-1. Zhang H; Wu G; Feng J; Lu X; Liu P J Orthop Surg Res; 2021 Nov; 16(1):667. PubMed ID: 34774067 [TBL] [Abstract][Full Text] [Related]
18. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity. Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082 [TBL] [Abstract][Full Text] [Related]
19. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma. Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648 [TBL] [Abstract][Full Text] [Related]
20. STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner. Sun S; Wu Y; Guo W; Yu F; Kong L; Ren Y; Wang Y; Yao X; Jing C; Zhang C; Liu M; Zhang Y; Zhao M; Li Z; Wu C; Qiao Y; Yang J; Wang X; Zhang L; Li M; Zhou X Clin Cancer Res; 2018 Jun; 24(11):2665-2677. PubMed ID: 29540490 [No Abstract] [Full Text] [Related] [Next] [New Search]